Centre for Oncology and Immunology is a research-led organization in Hong Kong conducting translational oncology work across immuno-oncology, organoid platforms, and biomarker discovery. The tech stack reflects a life-sciences operation: 10x Genomics, Illumina, and NanoString for sequencing and proteomic work; Python, R, and Perl for bioinformatics; and standard enterprise tools (Teams, Microsoft 365) for collaboration. Research dominates hiring (21 of 28 open roles), with a senior-weighted team (13 of 28 at senior level), indicating focus on specialized scientific talent over scaling operations.
Centre for Oncology and Immunology operates as a nonprofit research institute focused on discovering and developing novel cancer therapies, particularly through immuno-oncology and immunotherapy approaches. The organization comprises globally recognized researchers working on functional genomics, organoid-based cell models, biomarker discovery, and translational pathways from lab to clinical trial. Active projects span drug candidate identification, synthetic lethal interaction screening, and organoid technology platforms. The team operates across research (primary function), operations, engineering, and business development roles, with a hiring velocity that has recently slowed.
The Centre develops cancer therapies through immuno-oncology, organoid platforms, biomarker discovery, and functional genomics. Work includes novel drug development, anti-cancer compound screening, and translational research to bring candidates into clinical trials.
The organization uses 10x Genomics, Illumina, and NanoString for sequencing, proteomic analysis, and single-cell profiling. Bioinformatics work relies on Python, R, and Perl alongside standard lab informatics.
Other companies in the same industry, closest in size